AbbVie filed an 8-K reporting a material event related to Allergan Aesthetics, the company's aesthetics division housing Botox and Juvéderm. While the specific details require review of the full filing, material events in this context typically signal pricing adjustments, rebate program changes, or strategic shifts affecting the injectables market.
Business & M&A
AbbVie Files Material 8-K on Allergan Aesthetics — Pricing or Rebate Shift Likely Ahead
AbbVie disclosed a material event related to Allergan Aesthetics, signaling potential changes to Botox/Juvéderm pricing or Allē loyalty terms.
